Corvus Pharmaceuticals, Inc.
CRVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626971
No open-market purchases or sales by Corvus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 173 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Corvus Pharmaceuticals, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 47 | 48 | +1 |
| Shares | 25.6M | 22.1M | −3.51M (−13.7%) |
| Value | $25.4M | $18.1M | −$7.27M (−28.7%) |
New holders (6)
Institutions that held Corvus Pharmaceuticals, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bailard, Inc. | 39,998 | $33.0K | 0.00% |
| Jane Street Group, LLC | 20,775 | $17.0K | 0.00% |
| Susquehanna Fundamental Investments, LLC | 13,790 | $11.0K | 0.00% |
| Wolverine Trading, LLC | 10,688 | $8.00K | 0.00% |
| Royal Bank of Canada | 272 | $0 | 0.00% |
| China Universal Asset Management Co., Ltd. | 436 | $0 | 0.00% |
Sold out (5)
Institutions that held Corvus Pharmaceuticals, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Tang Capital Management LLC | 3,301,709 | $3.27M |
| Two Sigma Securities, LLC | 11,355 | $11.0K |
| Meeder Asset Management Inc | 1,984 | $2.00K |
| Optimum Investment Advisors | 1,000 | $1.00K |
| Total Clarity Wealth Management, Inc. | 500 | $0 |